Status:
UNKNOWN
Placental Pathology and Inflammatory Factor Analysis of OAPS
Lead Sponsor:
Peking University People's Hospital
Conditions:
Antiphospholipid Syndrome in Pregnancy
Eligibility:
FEMALE
18-50 years
Brief Summary
This investigation is on placental pathological changes and inflammatory factors associated with obstetric antiphospholipid syndrome.
Detailed Description
1\. To clarify the correlation between antiphospholipid antibody, ACC1 expression level, Treg cell and placental pathological changes associated with antiphospholipid syndrome. 2. Reveal that antiphos...
Eligibility Criteria
Inclusion
- pregnant women with antiphospholipid syndrome (diagnosed by experts with clinical evidence) and healthy pregnant women without antiphospholipid syndrome as a control group
- consent to join this study and finish the informed consents
Exclusion
- pregnant women with other autoimmune diseases
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05378516
Start Date
January 1 2022
End Date
December 31 2023
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PekingUPH
Beijing, China